SlideShare une entreprise Scribd logo
1  sur  16
“ Why Research on Rare Diseases” EURORDIS’ position paper Beatrice de Montleau Board member EURORDIS Amsterdam, 14 May 2011 www.eurordis.org
CONTENTS ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
History of research on RD within Eurordis ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
History of this Position Paper ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
History of this Position Paper ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
AIMS of the paper ,[object Object],[object Object],[object Object]
AIMS of the paper ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Part 1 – Ethical and social justice ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Part 1  (2) Part 1 – Ethical and social justice
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Part 2 Part 2 – The economic argument
[object Object],[object Object],[object Object],[object Object],Part 2  (2) Part 2 – The economic argument
[object Object],[object Object],[object Object],Part 3 Part 3 – Scientific trends
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Part 4 Part 4 – The way forward
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Part 4  (2) Part 4 – The way forward
[object Object],[object Object],[object Object],Conclusion: Patient involvement, a prerequisite
[object Object],[object Object],[object Object],Dissemination

Contenu connexe

Tendances

Conference 4 - The patient experience in the development and implementation ...
Conference 4 - The patient experience  in the development and implementation ...Conference 4 - The patient experience  in the development and implementation ...
Conference 4 - The patient experience in the development and implementation ...EURORDIS - Rare Diseases Europe
 
Conference 1 - EURORDIS’ recommendations for National Plans, Yann le Cam, EUR...
Conference 1 - EURORDIS’ recommendations for National Plans, Yann le Cam, EUR...Conference 1 - EURORDIS’ recommendations for National Plans, Yann le Cam, EUR...
Conference 1 - EURORDIS’ recommendations for National Plans, Yann le Cam, EUR...EURORDIS - Rare Diseases Europe
 
Workshop 6 - "Training package on RD for medical students"
Workshop 6 - "Training package on RD for medical students"Workshop 6 - "Training package on RD for medical students"
Workshop 6 - "Training package on RD for medical students"EURORDIS - Rare Diseases Europe
 
Workshop 2- "Feedback from the 15 National Conferences on Centres of Expertise"
Workshop 2- "Feedback from the 15 National Conferences on Centres of Expertise"Workshop 2- "Feedback from the 15 National Conferences on Centres of Expertise"
Workshop 2- "Feedback from the 15 National Conferences on Centres of Expertise"EURORDIS - Rare Diseases Europe
 
Workshop 3 - "Outcome of the RD Task Force and EPPOSI Workshop"
Workshop 3 - "Outcome of the RD Task Force and EPPOSI Workshop"Workshop 3 - "Outcome of the RD Task Force and EPPOSI Workshop"
Workshop 3 - "Outcome of the RD Task Force and EPPOSI Workshop"EURORDIS - Rare Diseases Europe
 
Workshop 3 - "Presentation of the concept, definitions and terminology"
Workshop 3 - "Presentation of the concept, definitions and terminology"Workshop 3 - "Presentation of the concept, definitions and terminology"
Workshop 3 - "Presentation of the concept, definitions and terminology"EURORDIS - Rare Diseases Europe
 
Workshop 2 - "EURORDIS Policy recommendations based on EURORDIS Declaration, ...
Workshop 2 - "EURORDIS Policy recommendations based on EURORDIS Declaration, ...Workshop 2 - "EURORDIS Policy recommendations based on EURORDIS Declaration, ...
Workshop 2 - "EURORDIS Policy recommendations based on EURORDIS Declaration, ...EURORDIS - Rare Diseases Europe
 
Workshop 7 - "Presentation of the International Federation for Spina Bifida a...
Workshop 7 - "Presentation of the International Federation for Spina Bifida a...Workshop 7 - "Presentation of the International Federation for Spina Bifida a...
Workshop 7 - "Presentation of the International Federation for Spina Bifida a...EURORDIS - Rare Diseases Europe
 
Workshop 5 - "Presentation of Social Challenges of RD patients in the Joint A...
Workshop 5 - "Presentation of Social Challenges of RD patients in the Joint A...Workshop 5 - "Presentation of Social Challenges of RD patients in the Joint A...
Workshop 5 - "Presentation of Social Challenges of RD patients in the Joint A...EURORDIS - Rare Diseases Europe
 
Workshop 6 - "Feedback from the 15 National Conferences"
Workshop 6 - "Feedback from the 15 National Conferences"Workshop 6 - "Feedback from the 15 National Conferences"
Workshop 6 - "Feedback from the 15 National Conferences"EURORDIS - Rare Diseases Europe
 
Workshop 5 - "Feedback from the 15 National Conferences on social aspects"
Workshop 5 - "Feedback from the 15 National Conferences on social aspects"Workshop 5 - "Feedback from the 15 National Conferences on social aspects"
Workshop 5 - "Feedback from the 15 National Conferences on social aspects"EURORDIS - Rare Diseases Europe
 
Workshop 6 - "Sharing expertise: transfer of experience from patient organiza...
Workshop 6 - "Sharing expertise: transfer of experience from patient organiza...Workshop 6 - "Sharing expertise: transfer of experience from patient organiza...
Workshop 6 - "Sharing expertise: transfer of experience from patient organiza...EURORDIS - Rare Diseases Europe
 
Introduction to the breakout sessions & case studies presentations
Introduction to the breakout sessions & case studies presentationsIntroduction to the breakout sessions & case studies presentations
Introduction to the breakout sessions & case studies presentationsEUPATI
 
G1 report from breakout group 1
G1 report from breakout group 1G1 report from breakout group 1
G1 report from breakout group 1EUPATI
 
EUPATI patient expert training course and its relevance for patient involvement
EUPATI patient expert training course and its relevance for patient involvementEUPATI patient expert training course and its relevance for patient involvement
EUPATI patient expert training course and its relevance for patient involvementEUPATI
 
G4 report from breakout group 4
G4 report from breakout group 4G4 report from breakout group 4
G4 report from breakout group 4EUPATI
 
EUPATI 2013 Conference: Vision on Patient involvement in medicines R&D: Here...
EUPATI 2013 Conference: Vision on Patient involvement in medicines R&D: Here...EUPATI 2013 Conference: Vision on Patient involvement in medicines R&D: Here...
EUPATI 2013 Conference: Vision on Patient involvement in medicines R&D: Here...EUPATI
 
EUPATI 2013 Conference: Building Knowledge & Competences for Patients’ Involv...
EUPATI 2013 Conference: Building Knowledge & Competences for Patients’ Involv...EUPATI 2013 Conference: Building Knowledge & Competences for Patients’ Involv...
EUPATI 2013 Conference: Building Knowledge & Competences for Patients’ Involv...EUPATI
 

Tendances (20)

Conference 4 - The patient experience in the development and implementation ...
Conference 4 - The patient experience  in the development and implementation ...Conference 4 - The patient experience  in the development and implementation ...
Conference 4 - The patient experience in the development and implementation ...
 
Conference 1 - EURORDIS’ recommendations for National Plans, Yann le Cam, EUR...
Conference 1 - EURORDIS’ recommendations for National Plans, Yann le Cam, EUR...Conference 1 - EURORDIS’ recommendations for National Plans, Yann le Cam, EUR...
Conference 1 - EURORDIS’ recommendations for National Plans, Yann le Cam, EUR...
 
Workshop 6 - "Training package on RD for medical students"
Workshop 6 - "Training package on RD for medical students"Workshop 6 - "Training package on RD for medical students"
Workshop 6 - "Training package on RD for medical students"
 
Workshop 2- "Feedback from the 15 National Conferences on Centres of Expertise"
Workshop 2- "Feedback from the 15 National Conferences on Centres of Expertise"Workshop 2- "Feedback from the 15 National Conferences on Centres of Expertise"
Workshop 2- "Feedback from the 15 National Conferences on Centres of Expertise"
 
Workshop 3 - "Outcome of the RD Task Force and EPPOSI Workshop"
Workshop 3 - "Outcome of the RD Task Force and EPPOSI Workshop"Workshop 3 - "Outcome of the RD Task Force and EPPOSI Workshop"
Workshop 3 - "Outcome of the RD Task Force and EPPOSI Workshop"
 
Workshop 7 - "Folic acid prevents neural tubes defect"
Workshop 7 - "Folic acid prevents neural tubes defect"Workshop 7 - "Folic acid prevents neural tubes defect"
Workshop 7 - "Folic acid prevents neural tubes defect"
 
Workshop 3 - "Presentation of the concept, definitions and terminology"
Workshop 3 - "Presentation of the concept, definitions and terminology"Workshop 3 - "Presentation of the concept, definitions and terminology"
Workshop 3 - "Presentation of the concept, definitions and terminology"
 
Workshop 2 - "EURORDIS Policy recommendations based on EURORDIS Declaration, ...
Workshop 2 - "EURORDIS Policy recommendations based on EURORDIS Declaration, ...Workshop 2 - "EURORDIS Policy recommendations based on EURORDIS Declaration, ...
Workshop 2 - "EURORDIS Policy recommendations based on EURORDIS Declaration, ...
 
Workshop 7 - "Presentation of the International Federation for Spina Bifida a...
Workshop 7 - "Presentation of the International Federation for Spina Bifida a...Workshop 7 - "Presentation of the International Federation for Spina Bifida a...
Workshop 7 - "Presentation of the International Federation for Spina Bifida a...
 
Workshop 5 - "Presentation of Social Challenges of RD patients in the Joint A...
Workshop 5 - "Presentation of Social Challenges of RD patients in the Joint A...Workshop 5 - "Presentation of Social Challenges of RD patients in the Joint A...
Workshop 5 - "Presentation of Social Challenges of RD patients in the Joint A...
 
Workshop 6 - "Feedback from the 15 National Conferences"
Workshop 6 - "Feedback from the 15 National Conferences"Workshop 6 - "Feedback from the 15 National Conferences"
Workshop 6 - "Feedback from the 15 National Conferences"
 
Workshop 5 - "Feedback from the 15 National Conferences on social aspects"
Workshop 5 - "Feedback from the 15 National Conferences on social aspects"Workshop 5 - "Feedback from the 15 National Conferences on social aspects"
Workshop 5 - "Feedback from the 15 National Conferences on social aspects"
 
Workshop 6 - "Case study: Italian Training for MDs,"
Workshop 6 - "Case study: Italian Training for MDs,"Workshop 6 - "Case study: Italian Training for MDs,"
Workshop 6 - "Case study: Italian Training for MDs,"
 
Workshop 6 - "Sharing expertise: transfer of experience from patient organiza...
Workshop 6 - "Sharing expertise: transfer of experience from patient organiza...Workshop 6 - "Sharing expertise: transfer of experience from patient organiza...
Workshop 6 - "Sharing expertise: transfer of experience from patient organiza...
 
Introduction to the breakout sessions & case studies presentations
Introduction to the breakout sessions & case studies presentationsIntroduction to the breakout sessions & case studies presentations
Introduction to the breakout sessions & case studies presentations
 
G1 report from breakout group 1
G1 report from breakout group 1G1 report from breakout group 1
G1 report from breakout group 1
 
EUPATI patient expert training course and its relevance for patient involvement
EUPATI patient expert training course and its relevance for patient involvementEUPATI patient expert training course and its relevance for patient involvement
EUPATI patient expert training course and its relevance for patient involvement
 
G4 report from breakout group 4
G4 report from breakout group 4G4 report from breakout group 4
G4 report from breakout group 4
 
EUPATI 2013 Conference: Vision on Patient involvement in medicines R&D: Here...
EUPATI 2013 Conference: Vision on Patient involvement in medicines R&D: Here...EUPATI 2013 Conference: Vision on Patient involvement in medicines R&D: Here...
EUPATI 2013 Conference: Vision on Patient involvement in medicines R&D: Here...
 
EUPATI 2013 Conference: Building Knowledge & Competences for Patients’ Involv...
EUPATI 2013 Conference: Building Knowledge & Competences for Patients’ Involv...EUPATI 2013 Conference: Building Knowledge & Competences for Patients’ Involv...
EUPATI 2013 Conference: Building Knowledge & Competences for Patients’ Involv...
 

Similaire à Workshop 4 - "EURORDIS Research Policy recommendation"

Daria Julkowska, E-Rare Net, Transforming Rare Disease Research through Trans...
Daria Julkowska, E-Rare Net, Transforming Rare Disease Research through Trans...Daria Julkowska, E-Rare Net, Transforming Rare Disease Research through Trans...
Daria Julkowska, E-Rare Net, Transforming Rare Disease Research through Trans...Canadian Organization for Rare Disorders
 
Existing resources, funding opportunities at EU and national levels
Existing resources, funding opportunities at EU and national levelsExisting resources, funding opportunities at EU and national levels
Existing resources, funding opportunities at EU and national levelsEURORDIS Rare Diseases Europe
 
European Union Action in the field of Rare Diseases
European Union Action in the field of Rare DiseasesEuropean Union Action in the field of Rare Diseases
European Union Action in the field of Rare DiseasesPlan de Calidad para el SNS
 
Montsserat Rtd Presentation Cluj 2009
Montsserat Rtd Presentation Cluj 2009Montsserat Rtd Presentation Cluj 2009
Montsserat Rtd Presentation Cluj 2009Mihaiela Fazacas
 
Catherine Hartmann Secretary General of the European COPD Coalition
Catherine Hartmann Secretary General of the European COPD CoalitionCatherine Hartmann Secretary General of the European COPD Coalition
Catherine Hartmann Secretary General of the European COPD CoalitionCittadinanzattiva onlus
 
Strengthening research. development and innovation cooperation between jordan...
Strengthening research. development and innovation cooperation between jordan...Strengthening research. development and innovation cooperation between jordan...
Strengthening research. development and innovation cooperation between jordan...SRTD _ II
 
Personal Health Systems: State-of-the-Art
Personal Health Systems: State-of-the-ArtPersonal Health Systems: State-of-the-Art
Personal Health Systems: State-of-the-ArtTotti Könnölä
 
Global Dementia Legacy Event: Canada & France: Dr Etienne Hirsch & Dr Yves Jo...
Global Dementia Legacy Event: Canada & France: Dr Etienne Hirsch & Dr Yves Jo...Global Dementia Legacy Event: Canada & France: Dr Etienne Hirsch & Dr Yves Jo...
Global Dementia Legacy Event: Canada & France: Dr Etienne Hirsch & Dr Yves Jo...Department of Health
 
Real World Outcomes Across the AD (Alzheimer’s disease) Spectrum (ROADS) to B...
Real World Outcomes Across the AD (Alzheimer’s disease) Spectrum (ROADS) to B...Real World Outcomes Across the AD (Alzheimer’s disease) Spectrum (ROADS) to B...
Real World Outcomes Across the AD (Alzheimer’s disease) Spectrum (ROADS) to B...Martin Pan
 
Graham Hughes - Beta Technology - FP 7 Call Presentation
Graham Hughes - Beta Technology - FP 7 Call PresentationGraham Hughes - Beta Technology - FP 7 Call Presentation
Graham Hughes - Beta Technology - FP 7 Call PresentationCK Group
 
UCD Rare Disease Module 2017 - Dr Derick Mitchell - March 28th 2017
UCD Rare Disease Module 2017 - Dr Derick Mitchell - March 28th 2017UCD Rare Disease Module 2017 - Dr Derick Mitchell - March 28th 2017
UCD Rare Disease Module 2017 - Dr Derick Mitchell - March 28th 2017ipposi
 
Medical Research Map for Finland
Medical Research Map for FinlandMedical Research Map for Finland
Medical Research Map for FinlandSitra / Hyvinvointi
 
Philippe Amouyel, JPND Milan Nov. 2013
Philippe Amouyel, JPND Milan Nov. 2013Philippe Amouyel, JPND Milan Nov. 2013
Philippe Amouyel, JPND Milan Nov. 2013jpndresearch
 
EU health research funding opportunities
EU health research funding opportunitiesEU health research funding opportunities
EU health research funding opportunitiesdoctrid2012
 

Similaire à Workshop 4 - "EURORDIS Research Policy recommendation" (20)

Sesion 2 terkel 14 05 2010 (final)
Sesion 2 terkel 14 05 2010 (final)Sesion 2 terkel 14 05 2010 (final)
Sesion 2 terkel 14 05 2010 (final)
 
Session 2 terkel_andersen
Session 2 terkel_andersenSession 2 terkel_andersen
Session 2 terkel_andersen
 
Daria Julkowska, E-Rare Net, Transforming Rare Disease Research through Trans...
Daria Julkowska, E-Rare Net, Transforming Rare Disease Research through Trans...Daria Julkowska, E-Rare Net, Transforming Rare Disease Research through Trans...
Daria Julkowska, E-Rare Net, Transforming Rare Disease Research through Trans...
 
Existing resources, funding opportunities at EU and national levels
Existing resources, funding opportunities at EU and national levelsExisting resources, funding opportunities at EU and national levels
Existing resources, funding opportunities at EU and national levels
 
European Union Action in the field of Rare Diseases
European Union Action in the field of Rare DiseasesEuropean Union Action in the field of Rare Diseases
European Union Action in the field of Rare Diseases
 
Antoni Montserrat
Antoni MontserratAntoni Montserrat
Antoni Montserrat
 
Session 25 antoni_montserrat
Session 25 antoni_montserratSession 25 antoni_montserrat
Session 25 antoni_montserrat
 
Montsserat Rtd Presentation Cluj 2009
Montsserat Rtd Presentation Cluj 2009Montsserat Rtd Presentation Cluj 2009
Montsserat Rtd Presentation Cluj 2009
 
Catherine Hartmann Secretary General of the European COPD Coalition
Catherine Hartmann Secretary General of the European COPD CoalitionCatherine Hartmann Secretary General of the European COPD Coalition
Catherine Hartmann Secretary General of the European COPD Coalition
 
Strengthening research. development and innovation cooperation between jordan...
Strengthening research. development and innovation cooperation between jordan...Strengthening research. development and innovation cooperation between jordan...
Strengthening research. development and innovation cooperation between jordan...
 
Personal Health Systems: State-of-the-Art
Personal Health Systems: State-of-the-ArtPersonal Health Systems: State-of-the-Art
Personal Health Systems: State-of-the-Art
 
Session 3 yann_le_cam
Session 3 yann_le_camSession 3 yann_le_cam
Session 3 yann_le_cam
 
Global Dementia Legacy Event: Canada & France: Dr Etienne Hirsch & Dr Yves Jo...
Global Dementia Legacy Event: Canada & France: Dr Etienne Hirsch & Dr Yves Jo...Global Dementia Legacy Event: Canada & France: Dr Etienne Hirsch & Dr Yves Jo...
Global Dementia Legacy Event: Canada & France: Dr Etienne Hirsch & Dr Yves Jo...
 
Real World Outcomes Across the AD (Alzheimer’s disease) Spectrum (ROADS) to B...
Real World Outcomes Across the AD (Alzheimer’s disease) Spectrum (ROADS) to B...Real World Outcomes Across the AD (Alzheimer’s disease) Spectrum (ROADS) to B...
Real World Outcomes Across the AD (Alzheimer’s disease) Spectrum (ROADS) to B...
 
Graham Hughes - Beta Technology - FP 7 Call Presentation
Graham Hughes - Beta Technology - FP 7 Call PresentationGraham Hughes - Beta Technology - FP 7 Call Presentation
Graham Hughes - Beta Technology - FP 7 Call Presentation
 
Julio E. Celis-Investigar, educar, dialogar
Julio E. Celis-Investigar, educar, dialogarJulio E. Celis-Investigar, educar, dialogar
Julio E. Celis-Investigar, educar, dialogar
 
UCD Rare Disease Module 2017 - Dr Derick Mitchell - March 28th 2017
UCD Rare Disease Module 2017 - Dr Derick Mitchell - March 28th 2017UCD Rare Disease Module 2017 - Dr Derick Mitchell - March 28th 2017
UCD Rare Disease Module 2017 - Dr Derick Mitchell - March 28th 2017
 
Medical Research Map for Finland
Medical Research Map for FinlandMedical Research Map for Finland
Medical Research Map for Finland
 
Philippe Amouyel, JPND Milan Nov. 2013
Philippe Amouyel, JPND Milan Nov. 2013Philippe Amouyel, JPND Milan Nov. 2013
Philippe Amouyel, JPND Milan Nov. 2013
 
EU health research funding opportunities
EU health research funding opportunitiesEU health research funding opportunities
EU health research funding opportunities
 

Plus de EURORDIS - Rare Diseases Europe

RareConnect.org webinar How to use Twitter to build your online rare disease ...
RareConnect.org webinar How to use Twitter to build your online rare disease ...RareConnect.org webinar How to use Twitter to build your online rare disease ...
RareConnect.org webinar How to use Twitter to build your online rare disease ...EURORDIS - Rare Diseases Europe
 
RareConnect.org webinar: How to start an awareness day for your rare disease
RareConnect.org webinar: How to start an awareness day for your rare diseaseRareConnect.org webinar: How to start an awareness day for your rare disease
RareConnect.org webinar: How to start an awareness day for your rare diseaseEURORDIS - Rare Diseases Europe
 
Update on the Mysasthenia Gravis community on RareConnect.org
Update on the Mysasthenia Gravis community on RareConnect.orgUpdate on the Mysasthenia Gravis community on RareConnect.org
Update on the Mysasthenia Gravis community on RareConnect.orgEURORDIS - Rare Diseases Europe
 
RareConnect.org - Connecting Rare Disease Patients Globally
RareConnect.org - Connecting Rare Disease Patients GloballyRareConnect.org - Connecting Rare Disease Patients Globally
RareConnect.org - Connecting Rare Disease Patients GloballyEURORDIS - Rare Diseases Europe
 
Results of Survey on the role of Patient Groups in Research and their priorit...
Results of Survey on the role of Patient Groups in Research and their priorit...Results of Survey on the role of Patient Groups in Research and their priorit...
Results of Survey on the role of Patient Groups in Research and their priorit...EURORDIS - Rare Diseases Europe
 
Results of Survey on the role of Patient Groups in Research and their priorit...
Results of Survey on the role of Patient Groups in Research and their priorit...Results of Survey on the role of Patient Groups in Research and their priorit...
Results of Survey on the role of Patient Groups in Research and their priorit...EURORDIS - Rare Diseases Europe
 
Results of a survey on the role of Patient Groups in Research and their prio...
Results of a survey on the role of Patient Groups in Research and their prio...Results of a survey on the role of Patient Groups in Research and their prio...
Results of a survey on the role of Patient Groups in Research and their prio...EURORDIS - Rare Diseases Europe
 
Conference 5 - “Patient’s Experience in the Development and Implementation of...
Conference 5 - “Patient’s Experience in the Development and Implementation of...Conference 5 - “Patient’s Experience in the Development and Implementation of...
Conference 5 - “Patient’s Experience in the Development and Implementation of...EURORDIS - Rare Diseases Europe
 
Workshop 3 - "Outcome of the RD Task Force and EPPOSI Workshop on registries"
Workshop 3 - "Outcome of the RD Task Force and EPPOSI Workshop on registries"Workshop 3 - "Outcome of the RD Task Force and EPPOSI Workshop on registries"
Workshop 3 - "Outcome of the RD Task Force and EPPOSI Workshop on registries"EURORDIS - Rare Diseases Europe
 

Plus de EURORDIS - Rare Diseases Europe (17)

RareConnect.org webinar How to use Twitter to build your online rare disease ...
RareConnect.org webinar How to use Twitter to build your online rare disease ...RareConnect.org webinar How to use Twitter to build your online rare disease ...
RareConnect.org webinar How to use Twitter to build your online rare disease ...
 
RareConnect.org Update 2016
RareConnect.org Update 2016RareConnect.org Update 2016
RareConnect.org Update 2016
 
RareConnect.org webinar: How to start an awareness day for your rare disease
RareConnect.org webinar: How to start an awareness day for your rare diseaseRareConnect.org webinar: How to start an awareness day for your rare disease
RareConnect.org webinar: How to start an awareness day for your rare disease
 
Living with TRAPS poll results
Living with TRAPS poll resultsLiving with TRAPS poll results
Living with TRAPS poll results
 
Pitt Hopkins syndrome community on RareConnect.org
Pitt Hopkins syndrome community on RareConnect.orgPitt Hopkins syndrome community on RareConnect.org
Pitt Hopkins syndrome community on RareConnect.org
 
The Value of Online Communities
The Value of Online CommunitiesThe Value of Online Communities
The Value of Online Communities
 
Updates to RareConnect.org in 2014
Updates to RareConnect.org in 2014Updates to RareConnect.org in 2014
Updates to RareConnect.org in 2014
 
Update on the Mysasthenia Gravis community on RareConnect.org
Update on the Mysasthenia Gravis community on RareConnect.orgUpdate on the Mysasthenia Gravis community on RareConnect.org
Update on the Mysasthenia Gravis community on RareConnect.org
 
Surveys and polls: The RareConnect.org Experience
Surveys and polls: The RareConnect.org ExperienceSurveys and polls: The RareConnect.org Experience
Surveys and polls: The RareConnect.org Experience
 
RareConnect.org - Connecting Rare Disease Patients Globally
RareConnect.org - Connecting Rare Disease Patients GloballyRareConnect.org - Connecting Rare Disease Patients Globally
RareConnect.org - Connecting Rare Disease Patients Globally
 
Rare disease day 2011 highlights
Rare disease day 2011 highlightsRare disease day 2011 highlights
Rare disease day 2011 highlights
 
Results of Survey on the role of Patient Groups in Research and their priorit...
Results of Survey on the role of Patient Groups in Research and their priorit...Results of Survey on the role of Patient Groups in Research and their priorit...
Results of Survey on the role of Patient Groups in Research and their priorit...
 
Results of Survey on the role of Patient Groups in Research and their priorit...
Results of Survey on the role of Patient Groups in Research and their priorit...Results of Survey on the role of Patient Groups in Research and their priorit...
Results of Survey on the role of Patient Groups in Research and their priorit...
 
Results of a survey on the role of Patient Groups in Research and their prio...
Results of a survey on the role of Patient Groups in Research and their prio...Results of a survey on the role of Patient Groups in Research and their prio...
Results of a survey on the role of Patient Groups in Research and their prio...
 
Conference 3 "Outcomes of 15 National Conferences, "
Conference 3   "Outcomes of 15 National Conferences, "Conference 3   "Outcomes of 15 National Conferences, "
Conference 3 "Outcomes of 15 National Conferences, "
 
Conference 5 - “Patient’s Experience in the Development and Implementation of...
Conference 5 - “Patient’s Experience in the Development and Implementation of...Conference 5 - “Patient’s Experience in the Development and Implementation of...
Conference 5 - “Patient’s Experience in the Development and Implementation of...
 
Workshop 3 - "Outcome of the RD Task Force and EPPOSI Workshop on registries"
Workshop 3 - "Outcome of the RD Task Force and EPPOSI Workshop on registries"Workshop 3 - "Outcome of the RD Task Force and EPPOSI Workshop on registries"
Workshop 3 - "Outcome of the RD Task Force and EPPOSI Workshop on registries"
 

Workshop 4 - "EURORDIS Research Policy recommendation"

  • 1. “ Why Research on Rare Diseases” EURORDIS’ position paper Beatrice de Montleau Board member EURORDIS Amsterdam, 14 May 2011 www.eurordis.org
  • 2.
  • 3.
  • 4.
  • 5.
  • 6.
  • 7.
  • 8.
  • 9.
  • 10.
  • 11.
  • 12.
  • 13.
  • 14.
  • 15.
  • 16.

Notes de l'éditeur

  1. With this slide want to underline the fact that for several years Eurordis has been advocating for RD research in EU. We can acknowledge several achievements but because of the high number of RD and the fact that research on most of them does not exist or is at very different stages of progress, the whole panel of instruments and efforts is still required and will be required for many and many years in the future.